Dennis Dean, Ph.D., appointed as Executive Vice President and Head of Non-Clinical Development at Odyssey Therapeutics.

EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or the “Company”) is pleased to announce two ...

How are AI, ML, robotics, and automation changing healthcare jobs? When I look across payers, providers, and life sciences, I ...

State’s proposal for $1 billion advocated for one-time investments that will spawn long-term improvements in workforce, ...

According to Motorsport.com Italy, Aston Martin have plucked a team member crucial during Ferrari’s title winning years ...

A recent poll of 500 global CEOs found that 94% believe AI could offer better counsel than at least one of their board ...

When Shelley wrote Frankenstein in 1818, anatomy was a science on the edge of revelation and respectability. Public ...

Baudrillard’s genius lay in foreseeing what these rudimentary devices like fax machines suggested about likely future uses of ...

Aerodynamics director Eric Blandin is understood to be among those who will be leaving the F1 design group in a reshuffle ...

Balochistan Chief Minister Mir Sarfraz Bugti has announced that all future appointments of Assistant Sub-Inspectors (ASIs) in ...

A brand-new simulation game that puts you in the wellies of a passionate veterinarian, My Life: Farm Vet, has launched on ...

Introduction Photobiomodulation (PBM) has shown promising effects in managing postoperative pain following conventional periapical surgery, although current evidence remains limited. This study aims ...